Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hansheng Pharmaceutical is a specialized pharmaceutical manufacturer located in Jinhua, Zhejiang Province, China. Originally established as a key production subsidiary of the Zhejiang Beisheng Pharmaceutical Group, the company focuses on the development and commercialization of chemical generic drugs. Its product portfolio spans several critical therapeutic areas, including cardiovascular diseases, anti-infectives, and gastrointestinal disorders. The company operates modern, GMP-certified manufacturing facilities capable of producing various oral solid dosage forms such as tablets, capsules, and granules. Hansheng Pharmaceutical is recognized for its core products like amlodipine besylate and clarithromycin, which serve the broad domestic Chinese healthcare market. Despite historical restructuring of its parent group, the company remains an active participant in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江北生药业汉生制药.